Fig. 6: The gene expression level of CDH1, which encodes E-cadherin, predicts the benefit of tamoxifen. | npj Breast Cancer

Fig. 6: The gene expression level of CDH1, which encodes E-cadherin, predicts the benefit of tamoxifen.

From: GATA3 and markers of epithelial-mesenchymal transition predict long-term benefit from tamoxifen in ER-positive breast cancer

Fig. 6

DRFI for the tamoxifen and controls groups in patients with low (a) and medium/high tumor CDH1 (b), in patients with low (c) and medium/high tumor FOXA1 (d), in patients with low (e) and medium/high tumor CDH2 (f), in patients with low (g) and medium/high tumor VIM (h). Hazard ratio (HR), tamoxifen (TAM), tertile (T).

Back to article page